Anticonvulsant levels and reloading: Difference between revisions
No edit summary |
No edit summary |
||
| Line 1: | Line 1: | ||
== Background == | == Background == | ||
*IV load can be performed with phenobarbital, phenytoin, valproate, levetiracetam | |||
*Oral loading can be spread over day or more to avoid GI upset | |||
=== Dose === | === Dose === | ||
| Line 25: | Line 27: | ||
=== Desired Level === | === Desired Level === | ||
*Pt's optimal level = desired level | |||
**If optimal level unknown target upper end of therapeutic range: | |||
***Phenytoin = 20 mcg/mL | |||
***Valproate = 100 mcg/mL | |||
***Phenobarbital = 40 mcg/mL | |||
== | ==Loading== | ||
*Phenytoin | |||
**IV: 10-20mg/kg at max rate of 25mg/min | |||
**PO: 18mg/kg as single dose or divided into 3 doses q2hr | |||
*Fosphenytoin | |||
**IV: 10-20mg phenytoin equivalent at max rate of 150mg/min | |||
==See Also== | ==See Also== | ||
[[Seizure (Peds)]] | *[[Seizure (Peds)]] | ||
*[[Febrile Seizure]] | |||
[[Febrile Seizure]] | *[[Dilantin Load]] | ||
*[[Depakote Loading]] | |||
[[Dilantin Load]] | |||
[[Depakote Loading]] | |||
==Source== | ==Source== | ||
Revision as of 09:46, 4 October 2011
Background
- IV load can be performed with phenobarbital, phenytoin, valproate, levetiracetam
- Oral loading can be spread over day or more to avoid GI upset
Dose
Dose (mg) = ideal body weight (kg) X Vd X [desired level - current level (mcg/mL)]
Volume of Distribution
| Agent |
Volume of Distribution |
| Phenytoin (dilantin) | 0.8 |
| Carbamazepine (tegretol) | 0.8 |
| Phenobarbital | 0.6 |
| Valproate (depakote) | 0.2 |
Desired Level
- Pt's optimal level = desired level
- If optimal level unknown target upper end of therapeutic range:
- Phenytoin = 20 mcg/mL
- Valproate = 100 mcg/mL
- Phenobarbital = 40 mcg/mL
- If optimal level unknown target upper end of therapeutic range:
Loading
- Phenytoin
- IV: 10-20mg/kg at max rate of 25mg/min
- PO: 18mg/kg as single dose or divided into 3 doses q2hr
- Fosphenytoin
- IV: 10-20mg phenytoin equivalent at max rate of 150mg/min
See Also
Source
DONALDSON 3/08 (from emedicine; Treiman 1997; Bourgeois, 1996)
